Back

Minisymposium

MS3H - AI in Life Sciences and Healthcare: Recent Advances, Challenges, and the Path Forward

Fully booked
Tuesday, June 4, 2024
11:00
-
13:00
CEST
HG F 26.5

Replay

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Session Chair

Description

Advances in Artificial Intelligence (AI) are reshaping life sciences and healthcare research. Our minisymposium explores AI's transformative role, delving into Computational Science, Computer Vision, and High-Performance Computing (HPC). Sessions span cancer research, personalized medicine, interactive machine learning, and privacy-preserving federated learning offering a panoramic view of AI's applications. In cancer research, Dr. Ellingson discusses the impact of developing models that integrate biological factors and social determinants of health using HPC. Precision imaging, spotlighted by Dr. Gichoya, leverages vast reservoirs of images to advance precision medicine while taking into account the serious ethical concerns. The minisymposium addresses the AI's black box challenge, crucial for trust and accountability. Dr. Jaeger shares human-centered approaches for recent developments in probabilistic modeling and explainable AI in cancer care. Challenges like data availability, scalability, and ethical AI practices are focal points. Dr. Madduri discusses federated learning's potential to build trustworthy AI in life sciences across institutions. The minisymposium aims to shape ethical standards, foster collaboration, and address the multifaceted challenges of guiding ethical AI integration in life sciences and healthcare. We aim to influence best practices and guidelines, propelling the synergy between AI and life sciences for the benefit of all of us.

Presentations

11:00
-
11:30
CEST
Unveiling the Tapestry: Exploring the Crucial Role of Social Determinants of Health in Cancer Research

This talk delves into the often underestimated yet pivotal role that social determinants of health (SDOH) play in the landscape of cancer research. Beyond the cellular and genetic intricacies, the broader context of an individual's life can significantly influence cancer outcomes. We will unravel the interconnected web of socioeconomic, cultural, and environmental factors that shape health disparities and impact cancer incidence, progression, and treatment responses. By acknowledging and understanding these determinants, we can pave the way for more inclusive and effective approaches in cancer research, fostering a comprehensive understanding of the complex interplay between biological factors and the diverse environments in which individuals live.

Sally Ellingson (University of Kentucky)
With Thorsten Kurth (NVIDIA Inc.)
11:30
-
12:00
CEST
Image Based Precision Medicine Using Artificial Intelligence

Recent studies have shown that both biologic and non-biologic disease-based characteristics can be predicted from medical imaging. For instance, self-reported race, sex, and age can be predicted from chest X-rays and other imaging modalities, as well as disease conditions, such as ICD code diagnoses. Additional research has indicated that disease risk, such as the risk of breast cancer, can be predicted from medical imaging with better performance than clinical and traditional scoring systems like the Tyrer-Cuzick and Gail breast cancer risk prediction. These models prove to be powerful even when they lack high precision labels from radiologists.

However, these image models face challenges due to the inadequacy of existing explanatory techniques. Furthermore, given the known issue of shortcut learning causing bias, there is increased concern over the use of image-only models.Conversely, if properly leveraged, image-only models can be successful, particularly for opportunistic screenings and mining information for population health, even if their initial intent was not for subsequent use.

I will discuss image-only models and their methodologies that have demonstrated superior performance over non-traditional imaging-only models, as well as the challenges and limitations of scaling imaging for precision medicine, specifically shortcut learning and limited explainability techniques.

Judy Gichoya (Emory University)
With Thorsten Kurth (NVIDIA Inc.)
12:00
-
12:30
CEST
Privacy-Preserving Federated Learning-as-a-Service: Building Trustworthy AI Models and Biomedical Insights

Federated learning (FL) is a collaborative learning approach where multiple data owners train a model together under the orchestration of a central server by sharing the model trained on their local datasets instead of sharing the data directly. FL enables creation of more robust models without the exposure of local datasets. However, FL by itself, does not guarantee the privacy of data, because the information extracted from the communication of FL algorithms can be accumulated and utilized to infer the private local data used for training. We developed Advanced Privacy Preserving Federated Learning framework (APPFL), with advances in differential privacy, to enable Privacy-Preserving Federated Learning (PPFL). We enabled PPFL through scaled, distributed training on supercomputing resources across multiple institutions to help create robust, trust-worthy AI models in biomedicine and smart grid applications. Setting up a secure high-performance computing FL experiment requires capabilities that may not be available for all. To lower the barrier for leveraging PPFL, we created the Advanced Privacy-Preserving Federated Learning as a service (APPFLx). APPFLx enables cross-silo PPFL with easy to use web interface for managing, deploying, analyzing, and visualizing PPFL experiments. In this talk, we will describe APPFLx and its adoption to biomedical use cases.

Ravi Madduri (Argonne National Laboratory, University of Chicago)
With Thorsten Kurth (NVIDIA Inc.)
12:30
-
13:00
CEST
AI in Life Sciences and Healthcare: Roundtable Discussion

This session will be an open discussion of developments, challenges and future directions of AI and life sciences, and how we can guide the way towards ethical, fair and effective integration.

Destinee Morrow (Lawrence Berkeley National Laboratory)
With Thorsten Kurth (NVIDIA Inc.)